B. Metzler seel. Sohn & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
B. Metzler seel. Sohn & Co's PFE Position: Q1 2026 in Review
B. Metzler seel. Sohn & Co reduced its Pfizer (PFE) stake by 5.2% in Q1 2026, selling an estimated $894K and leaving 606,068 shares worth $17M. The position accounts for 0.16% of the portfolio, ranked #78.
B. Metzler seel. Sohn & Co first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $237M in Q2 2021. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- B. Metzler seel. Sohn & Co held 606,068 shares of Pfizer worth $17M as of Q1 2026.
- B. Metzler seel. Sohn & Co sold 33,571 Pfizer shares in Q1 2026, an estimated $894K.
- Pfizer made up 0.16% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #78 holding.
- B. Metzler seel. Sohn & Co first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- B. Metzler seel. Sohn & Co's Pfizer position peaked at $237M in Q2 2021.
- 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.